New combo therapy may offer longer pain relief for facial pain sufferers
NCT ID NCT07304453
First seen Jan 04, 2026 · Last updated May 20, 2026 · Updated 19 times
Summary
This study tested a new combination of two supplements (Nucleo CMP and Neurorubine) against the standard drug carbamazepine for treating trigeminal neuralgia, a severe facial pain condition. 38 adults with the condition were randomly assigned to one of the two treatments. The goal was to see if the combination therapy could provide better pain control that lasts even after stopping treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROPATHIC PAIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Oral Medicine Clinic, College of Dentistry, University of Kerbala
Karbala, Kerbala, Iraq
Conditions
Explore the condition pages connected to this study.